Inactive Instrument
Company Guided Therapeutics Inc OTC Bulletin Board
Stocks
US40171F3038
Advanced Medical Equipment & Technology
Business description: Guided Therapeutics Inc

Sales by Activity: Guided Therapeutics Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Developing Innovative Medical Devices | 81K | 13K | 98K | 7K | 767K |
Executive Committee: Guided Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
Composition of the Board of Directors: Guided Therapeutics Inc
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
Richard Blumberg
BRD | Director/Board Member | 69 | 10/11/2016 |
Alan Grujic
BRD | Director/Board Member | 58 | 08/03/2023 |
Company details: Guided Therapeutics Inc
Guided Therapeutics, Inc.
5835 Peachtree Corners East
30092, Peachtree Corners
+770 242 8723
http://www.guidedinc.com
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | -1.13% | +27.04% | +14.12% | 233B | ||
| +0.18% | -1.27% | +5.25% | -17.37% | 152B | ||
| +1.51% | -1.64% | -21.37% | +23.59% | 130B | ||
| +0.36% | -7.01% | -55.71% | -12.92% | 67.64B | ||
| +0.29% | +0.47% | +11.06% | +18.65% | 51.85B | ||
| +0.66% | -1.69% | -16.57% | -13.62% | 50.91B | ||
| -2.44% | -3.25% | +23.11% | +28.29% | 44.46B | ||
| -1.56% | +0.97% | +39.32% | +47.34% | 41.39B | ||
| -5.31% | -1.74% | +117.39% | +36.28% | 34.38B | ||
| Average | -0.88% | -1.39% | +14.39% | +13.82% | 89.46B | |
| Weighted average by Cap. | -0.48% | -1.49% | +8.68% | +9.42% |

















